Leaderboards/cancer risks and factors

cancer risks and factors

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Rong Lin
Union Hospital
90
2
Ming Yi
Hangzhou First People's Hospital
50
3
Rui Sha
Wannan Medical College
40
4
Ya-bing Wang
Wannan Medical College
30
5
Ziyu Kuang
Beijing University of Chinese Medicine
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Gholamreza Roshandel
Golestan University
80
2
Pasquale Marino
Centro di Riferimento Oncologico della Basilicata
70
3
Jianhui Zhao
Second Affiliated Hospital of Zhejiang University
60
4
Junjie Huang
Chinese University of Hong Kong
50
5
Keren Papier
University of Oxford
40
6
Siyi He
Chinese Academy of Medical Sciences & Peking Union Medical College
30
7
Ryoko Katagiri
National Institute of Infectious Diseases
20
8
Changhwan Sung
Ulsan College
10
9
Jie Li
Chinese Academy of Medical Sciences & Peking Union Medical College
10

Emerging Leaders Papers

1
Associations between adoption of eHealth management module and optimal control of HbA1c in diabetes patients
npj Digital Medicine|2023
10 cit.
2
A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: repurposing drugs to identify novel disruptors of 14-3-3 proteins
Cell Death and Disease|2025
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Zeng‐Hong Wu
Union Hospital
99
2
Freddie Bray
Centre international de recherche sur le cancer
99
3
Michaël Pollak
Northwestern University
90
4
Priya Rastogi
UPMC Hillman Cancer Center
90
5
Ahmedin Jemal
American Cancer Society
80
6
Majid Ezzati
Harvard University
80
7
Farhad Islami
American Cancer Society
70
8
Meletios Α. Dimopoulos
National and Kapodistrian University of Athens
70
9
Alex A. Adjei
Roswell Park Comprehensive Cancer Center
60
10
Tianye Li
Second Affiliated Hospital of Zhejiang University
60

All-Time Leaders Papers

1
Global cancer statistics
CA A Cancer Journal for Clinicians|2011
55k cit.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
22.1k cit.
3
Cancer statistics, 2019
CA A Cancer Journal for Clinicians|2019
20.9k cit.
4
Cancer Statistics, 2021
CA A Cancer Journal for Clinicians|2021
17.3k cit.
5
Cancer statistics, 2023
CA A Cancer Journal for Clinicians|2023
16.5k cit.
6
Cancer statistics, 2024
CA A Cancer Journal for Clinicians|2024
8.8k cit.
7
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
The Lancet|2011
4.1k cit.
8
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
PLoS Medicine|2009
2.9k cit.
9
Cancer treatment and survivorship statistics, 2014
CA A Cancer Journal for Clinicians|2014
2.8k cit.
10
Cancer statistics, 2025
CA A Cancer Journal for Clinicians|2025
2.2k cit.

Reagents for cancer risks and factors

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

NCAM1 (CD56) (123C3) Mouse Monoclonal Antibody

Cited in 7 papers
#3576$156
View Evidence →Cell Signaling Technology

GCN2 Antibody

Cited in 6 papers
#3302$317
View Evidence →Cell Signaling Technology

eEF1A (D10A5) Rabbit Monoclonal Antibody

Cited in 6 papers
#3586$161
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Progesterone Receptor

Cited in 12 papers
#M3569
View Evidence →Cell Signaling Technology

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 10 papers
#94805$465
View Evidence →Agilent/Dako

Estrogen Receptor ?

Cited in 9 papers
#M7047
View Evidence →